Project Details
Description
Development of the brain penetrant ATM inhibitor WSD0628 in combination with radiation for recurrent high grade glioma
| Status | Active |
|---|---|
| Effective start/end date | 9/10/23 → 5/31/24 |
Funding
- MAYO CLINIC ROCHESTER
- DHHS FOOD & DRUG ADMINISTRATION (FDA)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.